WO1997023631A3 - Globins containing binding domains - Google Patents
Globins containing binding domains Download PDFInfo
- Publication number
- WO1997023631A3 WO1997023631A3 PCT/US1996/020632 US9620632W WO9723631A3 WO 1997023631 A3 WO1997023631 A3 WO 1997023631A3 US 9620632 W US9620632 W US 9620632W WO 9723631 A3 WO9723631 A3 WO 9723631A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- binding domains
- containing binding
- globins
- naturally occurring
- domains
- Prior art date
Links
- 102000018146 globin Human genes 0.000 title abstract 3
- 108060003196 globin Proteins 0.000 title abstract 3
- INGWEZCOABYORO-UHFFFAOYSA-N 2-(furan-2-yl)-7-methyl-1h-1,8-naphthyridin-4-one Chemical compound N=1C2=NC(C)=CC=C2C(O)=CC=1C1=CC=CO1 INGWEZCOABYORO-UHFFFAOYSA-N 0.000 abstract 1
- 102000001554 Hemoglobins Human genes 0.000 abstract 1
- 108010054147 Hemoglobins Proteins 0.000 abstract 1
- 108020001756 ligand binding domains Proteins 0.000 abstract 1
- 230000003606 oligomerizing effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
- C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/465—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from birds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4746—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used p53
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/795—Porphyrin- or corrin-ring-containing peptides
- C07K14/805—Haemoglobins; Myoglobins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/10011—Details dsDNA Bacteriophages
- C12N2795/10311—Siphoviridae
- C12N2795/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Mycology (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP96945282A EP0868521A2 (en) | 1995-12-22 | 1996-12-20 | Globins containing binding domains |
CA002239303A CA2239303A1 (en) | 1995-12-22 | 1996-12-20 | Globins containing binding domains |
US09/091,814 US6218513B1 (en) | 1995-12-22 | 1996-12-20 | Globins containing binding domains |
JP9523865A JP2000504934A (en) | 1995-12-22 | 1996-12-20 | Globin containing binding domain |
AU14689/97A AU715914B2 (en) | 1995-12-22 | 1996-12-20 | Globins containing binding domains |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3200195P | 1995-12-22 | 1995-12-22 | |
US2100195P | 1995-12-22 | 1995-12-22 | |
US60/021,001 | 1995-12-22 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1997023631A2 WO1997023631A2 (en) | 1997-07-03 |
WO1997023631A3 true WO1997023631A3 (en) | 1997-10-23 |
Family
ID=26694138
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1996/020632 WO1997023631A2 (en) | 1995-12-22 | 1996-12-20 | Globins containing binding domains |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO1997023631A2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6022849A (en) * | 1987-05-16 | 2000-02-08 | Baxter Biotech Technology Saarl | Mutant recombinant hemoglobins containing heme pocket mutations |
US6204009B1 (en) | 1988-05-16 | 2001-03-20 | BAXTER BIOTECH TECHNOLOGY SàRL | Nucleic acids encoding mutant recombinant hemoglobins containing heme pocket mutations |
DE69839263T2 (en) | 1997-05-02 | 2009-04-30 | Baxter Biotech Technology S.A.R.L. | Hemoglobin mutants with reduced nitrogen (mon) oxide removal capacity |
EP1950298A3 (en) | 1997-05-02 | 2008-12-24 | Baxter Biotech Technology S.A.R.L. | Hemoglobin mutants with increased soluble expression and/or reduced nitric oxide scavenging |
JP2005522192A (en) * | 2001-07-19 | 2005-07-28 | パーラン セラピューティクス, インコーポレイテッド | Multimeric proteins and methods of making and using multimeric proteins |
KR101955928B1 (en) * | 2016-12-30 | 2019-03-08 | 경상대학교산학협력단 | Multimer fusion protein comprising hagfish VLRB hydrophobic tail domain |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990013645A1 (en) * | 1989-05-10 | 1990-11-15 | Somatogen, Inc. | Production in bacteria and yeast of hemoglobin and analogues thereof |
WO1991019505A1 (en) * | 1990-06-20 | 1991-12-26 | Research Corporation Technologies, Inc. | Modified human hemoglobin, blood substitutes containing the same, and vectors for expressing the modified hemoglobin |
WO1993009143A1 (en) * | 1991-11-08 | 1993-05-13 | Somatogen, Inc. | Production and use of multimeric hemoglobins |
WO1995014038A2 (en) * | 1993-11-15 | 1995-05-26 | Somatogen, Inc. | Purification of hemoglobin |
WO1996040920A1 (en) * | 1992-11-06 | 1996-12-19 | Somatogen, Inc. | Modified hemoglobin-like compounds and methods of purifying same |
-
1996
- 1996-12-20 WO PCT/US1996/020632 patent/WO1997023631A2/en not_active Application Discontinuation
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990013645A1 (en) * | 1989-05-10 | 1990-11-15 | Somatogen, Inc. | Production in bacteria and yeast of hemoglobin and analogues thereof |
WO1991019505A1 (en) * | 1990-06-20 | 1991-12-26 | Research Corporation Technologies, Inc. | Modified human hemoglobin, blood substitutes containing the same, and vectors for expressing the modified hemoglobin |
WO1993009143A1 (en) * | 1991-11-08 | 1993-05-13 | Somatogen, Inc. | Production and use of multimeric hemoglobins |
WO1996040920A1 (en) * | 1992-11-06 | 1996-12-19 | Somatogen, Inc. | Modified hemoglobin-like compounds and methods of purifying same |
WO1995014038A2 (en) * | 1993-11-15 | 1995-05-26 | Somatogen, Inc. | Purification of hemoglobin |
Non-Patent Citations (4)
Title |
---|
J.A. PIETENPOL ET AL.: "Sequence-specific transcriptional activation is essential for growth suppression by p53", PROC. NATL.ACAD SCI., vol. 91, March 1994 (1994-03-01), NATL. ACAD SCI.,WASHINGTON,DC,US;, pages 1998 - 2002, XP002039245 * |
J.C. HU ET AL.: "Sequence requirements for coiled-coils: Analysis with lambda repressor-GCN4 leucine zipper fusions", SCIENCE, vol. 250, 7 December 1990 (1990-12-07), AAAS,WASHINGTON,DC,US, pages 1400 - 1403, XP002039244 * |
P. PACK AND A. PLÜCKTHUN: "Miniantibodies: Use of amphipathic helices to produce functional, flexibly linked dimeric Fv fragments with high avidity in Escherichia coli", BIOCHEMISTRY, vol. 31, no. 6, 18 February 1992 (1992-02-18), AM. CHEM. SOC.,WASHINGTON,DC,US, pages 1579 - 1584, XP002039243 * |
V.P. EFIMOV ET AL.: "The thrombospondin-like chain of cartilage oligomeric matrix protein are assembled by a five-stranded alpha-helical bundle between residue 20 and 83", FEBS LETTERS, vol. 341, no. 1, 14 March 1994 (1994-03-14), ELSEVIER, AMSTERDAM, NL, pages 54 - 58, XP002039242 * |
Also Published As
Publication number | Publication date |
---|---|
WO1997023631A2 (en) | 1997-07-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0143832A4 (en) | Modified crosslinked stroma-free tetrameric hemoglobin. | |
DE69529517D1 (en) | CIRCULAR PERMUTED LIGANDS AND CIRCULAR PERMUTED CHIMERIC MOLECULES | |
EP1961760A3 (en) | Peptides and compounds that bind to a thrombopoietin receptor | |
BR9710538A (en) | Binding metal content bleaching compositions | |
ZA977837B (en) | Catalyst composition containing oxygen storage components. | |
CA2202239A1 (en) | Liquid absorbent solutions for separating nitrogen from natural gas | |
AU6054894A (en) | Narrow band Mach-Zehnder filter | |
HUP9904052A3 (en) | Monoclonal antibodies againts the extracellular domain of human vegf-receptor protein (kdr) | |
NL300238I1 (en) | ||
AU7332198A (en) | Lentivirus based vector and vector system | |
ZA948551B (en) | Chimeric proteins comprising borrelia polypeptides; uses therefor | |
WO1997023631A3 (en) | Globins containing binding domains | |
EP0700684A3 (en) | Composition containing prothrombincomplex-concentrate and at least one additional component which activates the coagulation, as antidote for blood-anticoagulants | |
AU3217595A (en) | Stabilized compositions containing hemoglobin | |
WO2000034447A8 (en) | Human ubiquitin ligase e3 for the modulation of nf-kappa b | |
DE69419240D1 (en) | Catalyst for lowering the benzene content of gasolines | |
FR2702388B1 (en) | Safety binding with angular adjustments for snowboarding. | |
FR2772200B1 (en) | ROUTING ACCESSORY FOR CHUTE, SUCH AS ANGLE OR BYPASS | |
WO2001011051A3 (en) | Chimeric proteins | |
AU2222497A (en) | Semi-submersible vessels | |
AU1261395A (en) | Antibodies which inhibit the binding of thrombin to platelets | |
IE841297L (en) | Aryloxycycloalkanolaminoalkylene aryl ketones. | |
WO2000031254A3 (en) | Apoptosis-inducing factor | |
AU3392395A (en) | Sailing vessels | |
NO972037D0 (en) | Port for vessels |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG |
|
ENP | Entry into the national phase |
Ref document number: 2239303 Country of ref document: CA Ref country code: CA Ref document number: 2239303 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1996945282 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09091814 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 1996945282 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1996945282 Country of ref document: EP |